000 01171 a2200337 4500
005 20250513042013.0
264 0 _c19950608
008 199506s 0 0 eng d
022 _a0315-162X
040 _aNLM
_beng
_cNLM
100 1 _aCrilly, A
245 0 0 _aInterleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
_h[electronic resource]
260 _bThe Journal of rheumatology
_cFeb 1995
300 _a224-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aArthritis, Rheumatoid
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aReceptors, Interleukin-2
_xmetabolism
650 0 4 _aSolubility
700 1 _aMcInness, I B
700 1 _aMcDonald, A G
700 1 _aWatson, J
700 1 _aCapell, H A
700 1 _aMadhok, R
773 0 _tThe Journal of rheumatology
_gvol. 22
_gno. 2
_gp. 224-6
999 _c7738311
_d7738311